Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder

71Citations
Citations of this article
93Readers
Mendeley users who have this article in their library.

Abstract

The biological consequences of exposure to explosive blast are extremely complex. Serum protein biomarkers in blast-induced traumatic brain injury (bTBI) can aid in determining injury severity, monitoring progress, and predicting outcome. Exposure to blast results in varying degrees of physical injury. Explosive blast can also induce psychological stress that can contribute to or amplify the extent of physical damage. Given the complexity, scale of injury, and variety of symptoms, bTBI may be best described as a spectrum disorder. In this focused review, we summarize the status of serum protein biomarkers in bTBI in the context of the classification and pathological changes of other forms of TBI. Finally, we recommend specific and easily implementable measures to accelerate serum protein biomarker discovery and validation in bTBI. © 2012 Agoston and Elsayed.

Cite

CITATION STYLE

APA

Agoston, D. V., & Elsayed, M. (2012). Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder. Frontiers in Neurology, JUL. https://doi.org/10.3389/fneur.2012.00107

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free